Endorsement Initiative Update Agenda Electronic Support for Endorsements 29 March 2012.
Four-year clinical outcomes of the OLIVUS-Ex Atherosclerosis
Acta Pharmaceutica Volume 63 Issue 1 Pages 131 140
Pharm Dev Technol. 2010 design and in vitro evaluation of novel sustained-release matrix tablets for lornoxicam base on the combination of hydrophilic matrix formrs and basic ph-modifiers